Senator Bernie Sanders calls for price cuts on diabetes and obesity drugs Ozempic and Wegovy, made by Novo Nordisk, due to their high US prices.

Senator Bernie Sanders calls for price cuts on diabetes and obesity drugs Ozempic and Wegovy, made by Novo Nordisk, describing their US prices as "outrageously high." Sanders urges Denmark to put pressure on Novo Nordisk, the country's largest business, to reduce drug prices. The senator claims Novo charges around 10 times more for Ozempic in the US than in some European countries.